Riskpilot← Back to searchSign inGet full accessBRUMUNDDAL LEGESENTER AS
ASActiveOrg 911557207Nygata 22A, 2380 BrumunddalGeneral medical practice activities · NACE 8621Est. 201317 employees
Revenue 2024
NOK 19,1M
+10% vs 2023
EBITDA margin
2.4%
+5% vs 2023
Equity ratio
13.5%
Financial strength
Net profit 2024
NOK 0
17 employees
| Revenue | NOK 19,1M | +10% |
| EBITDA | NOK 457K | +5% |
| Net profit | NOK 0 | — |
| Total assets | NOK 4,5M | +18% |
| Equity | NOK 607K | +0% |
| Employees | 17 | — |
Legal name
BRUMUNDDAL LEGESENTER AS
Org number
911557207
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
12. februar 2013
Share capital
NOK 55 000
Employees
17 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Å drive legesentervirksomhet i brumunddal med alt det innebærer, herunder å delta og eie i andre selskaper.
Address
Nygata 22A, 2380 Brumunddal
Phone
+4762330300
Email
post@bls.as
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 283 | 3 379 | 4 886 | 17 404 | 19 072 |
| Staff expenses | −5 977 | −8 081 | −8 342 | −10 581 | −11 109 |
| EBITDA | 296 | 277 | −1 126 | 437 | 457 |
| Depreciation & amort. | −256 | −249 | −337 | −409 | −385 |
| EBIT | 40 | 28 | −1 462 | 28 | 73 |
| Net financials | −40 | −28 | −23 | −28 | −73 |
| Profit before tax | 0 | 0 | −1 485 | 0 | 0 |
| Tax | 20 | −0 | −0 | −0 | −0 |
| Net profit | −20 | 0 | −1 485 | 0 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 599 | 2 944 | 4 218 | 3 823 | 4 495 |
| Equity | 592 | 592 | 607 | 607 | 607 |
| Long-term debt | 408 | 357 | 300 | 289 | 950 |
| Short-term debt | 1 599 | 1 995 | 3 310 | 2 927 | 2 938 |
| Total debt | 2 007 | 2 352 | 3 610 | 3 216 | 3 888 |
EBITDA margin
2.4%
This company
15.8%
Market median
-85% vs market
20202024
Equity ratio
13.5%
This company
38.2%
Market median
-65% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
4.24×
This company
1.12×
Market median
+279% vs market
20202024
Debt / equity
6.40×
This company
0.62×
Market median
-932% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2025 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2022 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BRUMUNDDAL LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Siri Kristin Engebretsen | Board of Directors | 0 companies |
| Amanish Kumar | Board of Directors | 0 companies |
| Brian Zamel | Board of Directors | 0 companies |